Oral treprostinil for the treatment of pulmonary arterial hypertension in patients transitioned from parenteral or inhaled prostacyclins: case series and treatment protocol

Abstract. Oral treprostinil (TRE) is a prostacylin approved for the management of pulmonary arterial hypertension (PAH). Few data exist to guide the use of oral TRE as a replacement for parenteral or inhaled prostacyclins. Therefore, the purpose of this report was to describe our experience with ora...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pulm Circ
Auteurs principaux: Coons, James C., Miller, Taylor, Simon, Marc A., Ishizawar, David C., Mathier, Michael A.
Format: Artigo
Langue:Inglês
Publié: University of Chicago Press 2016
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4860543/
https://ncbi.nlm.nih.gov/pubmed/27162621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685111
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires